IP Library Granted Patent US 11,129,404
Granted Patent B2
US 11,129,404 · App. 16/066,585 · Granted Sep 28, 2021

Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof

Inventors: Tapas Das (Worthington, OH); Mustafa Vurma (Dublin, OH); Chron-Si Lai (Blacklick, OH); Paul Johns (Columbus, OH)
Assignee: ABBOTT LABORATORIES
A23L33/40A23L29/035A23L33/115A23L33/12A23L33/18A23L33/19A61K38/018A61K45/06A61P25/28A23L33/125A23V2002/00A23V2200/322A23V2250/186A23V2250/1842A23V2250/192A23V2250/30A23V2250/54246A23V2250/54252A61K31/575A61K31/685A61K2300/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,129,404
App. No.
16/066,585
Granted
Sep 28, 2021
Kind
B2
Abstract

Disclosed embodiments provide nutritional compositions and methods of enhancing maturation of an infant's brain. The methods include the step of administering to the infant a nutritional composition comprising a protein with a degree of hydrolysis of 10% to 75% in combination with at least one of a monoglyceride, a free fatty acid, a salt of a free fatty acid, a phospholipid, and cholesterol.

Claims (13)

1. A method of inhibiting neuronal cell death in an infant in need thereof, the method comprising administering to the infant a nutritional composition consisting essentially of a casein protein with a degree of hydrolysis of 10% to 75% and a mixture of a monoglycerol palmitate, soy lecithin, cholesterol, and at least one of a free fatty acid from soy and a salt of a free fatty acid from soy, and wherein after administration the infant's neuronal cell death is reduced.

2. The method of claim 1 , wherein the infant in need thereof is a preterm infant.

3. The method of claim 1 , wherein the nutritional composition is a human milk fortifier.

4. The method of claim 1 , wherein the nutritional composition is a powdered human milk fortifier.

5. The method of claim 1 , wherein the nutritional composition is an infant formula.

6. The method of claim 5 , wherein the nutritional composition is a preterm infant formula.

7. The method of claim 1 , wherein the nutritional composition further comprises a carbohydrate.

8. A method of treating neuronal tissue inflammation in an infant in need thereof, the method comprising administering to the infant a nutritional composition consisting essentially of a casein protein with a degree of hydrolysis of 10% to 75% and a mixture of a monoglycerol palmitate, soy lecithin, cholesterol, and at least one of a free fatty acid from soy and a salt of a free fatty acid from soy, and wherein after administration the infant's neuronal tissue inflammation is reduced.

9. The method of claim 8 , wherein the nutritional composition is a human milk fortifier.

10. The method of claim 9 , wherein the nutritional composition is a powdered human milk fortifier.

11. The method of claim 8 , wherein the nutritional composition is an infant formula.

12. The method of claim 11 , wherein the nutritional composition is a preterm infant formula.

13. A method of reducing neuronal tissue inflammation in an infant in need thereof, the method comprising administering to the infant a nutritional composition consisting essentially of a casein protein with a degree of hydrolysis of 10% to 75% and a mixture of a monoglycerol palmitate, soy lecithin, cholesterol, and at least one of a free fatty acid from soy and a salt of a free fatty acid from soy.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2018
From: DAS, TAPAS; VURMA, MUSTAFA; LAI, CHRON-SI; JOHNS, PAUL
To: ABBOTT LABORATORIES
Reel/Frame 047336/0735 →
Continuity (2)
Provisional Application 62271644 · Dec 28, 2015
Related Publication 20190014807A1 · Jan 17, 2019